Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion

Fertil Steril. 2019 Dec;112(6):1022-1033. doi: 10.1016/j.fertnstert.2019.09.013.

Abstract

Patients preparing to undergo gonadotoxic medical therapy, radiation therapy, or gonadectomy should be provided with prompt counseling regarding available options for fertility preservation for iatrogenic infertility. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients. This document replaces the document with a similar name, last published in 2013.

Publication types

  • Comparative Study
  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Castration / adverse effects*
  • Female
  • Fertility / drug effects
  • Fertility / radiation effects
  • Fertility Preservation* / adverse effects
  • Humans
  • Iatrogenic Disease*
  • Infertility, Female / etiology
  • Infertility, Female / physiopathology
  • Infertility, Female / therapy*
  • Infertility, Male / etiology
  • Infertility, Male / physiopathology
  • Infertility, Male / therapy*
  • Male
  • Radiation Injuries / etiology
  • Radiation Injuries / physiopathology
  • Radiation Injuries / therapy*
  • Radiotherapy / adverse effects
  • Reproductive Techniques, Assisted* / adverse effects
  • Risk Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents